NextCell Pharma Stock

NextCell Pharma P/B

The P/B (Price-to-Book Ratio) of NextCell Pharma (NXTCL.ST) as of Aug 13, 2026 is 2.41. In the previous year, P/B (Price-to-Book Ratio) was 2.37 — a change of 1.82% (higher).

P/B

2.41

YoY

1.82%

Last updated:

P/B (Price-to-Book Ratio) of NextCell Pharma is 2026 2.41 . P/B (Price-to-Book Ratio) of NextCell Pharma was 2025 2.37 . It decreases by 1.82% higher compared to the previous year.
Access this data via the Eulerpool API

NextCell Pharma Stock analysis

What does NextCell Pharma do? NextCell Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NextCell Pharma stock

P/B (Price-to-Book Ratio) of NextCell Pharma is 2.41 in 2026.

P/B (Price-to-Book Ratio) of NextCell Pharma changed from 2.37 to 2.41, representing a 1.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) NextCell Pharma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s NextCell Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — NextCell Pharma

All Key Metrics — NextCell Pharma